Paper of the Month - 2009

0 rating

HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer.

Lang JE, Mosalpuria K, Cristofanilli M et al.


READER POLL

Breast Cancer Poll 1
What approach do you currently use for the treatment of patients with HER2-overexpressing metastatic breast cancer whose disease has progressed despite trastuzumab?






Powered by NetPolls

WEB LINKS

SUBMIT AN ARTICLE